Association of CYP1A1 germ line polymorphisms with mutations of the p53 gene in lung cancer

Cancer Research

Volumn 56, Issue 1, 1996, Pages 72-76

  Kawajiri, Kaname ^a   Eguchi, Hidetaka ^a   Nakachi, Kei ^a   Sekiya, Takao ^b   Yamamoto, Mitsunobu ^a  

^a SAITAMA CANCER CENTER   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; DRUG METABOLIZING ENZYME; PROTEIN P53;

ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GERM LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; SMOKING;

CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GENE FREQUENCY; GLUTATHIONE TRANSFERASE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC; SMOKING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030045915     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. McManus, M. E., Burgess, W. M., Veronese, M. E., Huggett, A., Quattorochi, L. C., and Tukey, R. H. Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochrome P450. Cancer Res , 50: 3367-3376, 1990.
2. Shimada, T., Yun, C-H., Yamazaki, H., Gautier, J-C., Beaune, P. H , and Guengerich, F. P. Characterization of human lung microsomal cytochrome P450 1A1 and its role in oxidation of chemical carcinogens. Mol. Pharmacol., 41: 856-864, 1992.
3. Mannervik, B., and Danielson, U. H. Glutathione transferases: structure and catalytic activity. Crit. Rev Biochem. Mol. Biol , 23: 281-337, 1988.
4. Nebert, D. W. Role of genetics and drug metabolism in human cancer risk. Mutat. Res., 247: 259-266, 1991
5. Caporaso, N , Landi, M. T., and Vineis, P. Relevance of metabolic polymorphisms to human carcinogenesis: evaluation of epidemiologic evidence. Pharmacogenetics, 1: 4-19, 1991.
6. Kawajiri, K., and Fujii-Kuriyama, Y. P450 and human cancer. Jpn. J. Cancer Res., 82: 1325-1335, 1991.
7. Kawajiri, K., Nakachi, K., Imai, K., Yoshii, A., Shinoda, N , and Watanabe, J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene FEBS Lett , 263: 131-133, 1990.
8. Hayashi, S-I , Watanabe, J., Nakachi, K., and Kawajiri, K. Genetic linkage of lung cancer-associated Msp I polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450 1A1 gene. J. Biochem., 110: 407-411, 1991.
9. Kawajiri, K., Nakachi, K , Imai, K., Watanabe, J., and Hayashi, S-I. The CYP1A1 gene and cancer susceptibility. Crit. Rev. Oncol. Hematol., 14: 77-87, 1993
10. Nakachi, K., Imai, K., Hayashi, S-I., Watanabe, J., and Kawajiri, K. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res , 51: 5177-5180, 1991.
11. Hayashi, S-I., Watanabe, J , and Kawajiri, K. High susceptibility to lung cancer analyzed in terms of combined genotypes of P4501A1 and Mu-class glutathione 5-transferase genes Jpn J. Cancer Res., 83: 866-870, 1992.
12. Nakachi, K., Imai, K., Hayashi, S-I., and Kawajiri, K. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population Cancer Res., 53: 2994-2999, 1993.
13. Petersen, D D., McKinney, C E , Ikeya, K , Smith, H. H , Bale, A. E., McBride, O W , and Nebert, D. W. Human CYP1A1 gene Cosegregation of the enzyme inducibility phenotype and RFLP Am. J Hum Genet , 48: 720-725, 1991.
14. Crofts, F , Taioli, E., Trachman, J., Cosma, G N., Currie, D , Toniolo, P., and Garte, S. J. Functional significance of different human CYP1A1 genotypes. Carcinogenesis (Lond.), 15: 2961-2963, 1994.
15. Seidegård, J , Vorachek, W. R., Pero, W. R., and Pearson, W. R. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion Proc. Natl. Acad. Sci. USA, 85: 7293-7297, 1988.
16. Minna, J D., Battey, J. F , Brooks, B. J., Cuttitta, F., Gazdar, A F , Johnson, B. E., Ihde, D C., Lebacq-Verheyden, A-M., Mulshine, J., Nau, M. M., Oie, H. K., Sausville, E. A., Seifter, E , and Vinocour, M. Molecular genetic analysis reveals chromosomal deletion, gene amplification, and autocrine growth factor production in the pathogenesis of human lung cancer. Cold Spring Harbor Symp Quant. Biol , 51: 843-853, 1986.
17. Weinberg, R. A. Tumor suppressor genes Science (Washington DC), 254: 1138-1145, 1991
18. Weinberg, R. A. Oncogenes, tumor suppressor genes, and cell transformation: trying to put it all together. In. Brugge, J., Curran, T., Harlow, E. D., and McCormick, F. (eds), Origins of Human Cancer A Comprehensive Review, pp. 1-16 Cold Spring Harbour, NY: Cold Spring Harbor Laboratory Press, 1991
19. Takahashi, T , Nau, M. M , Chiba, I., Birrer, M. J., Rosenberg, R. K., Vinocour, M., Levitt, M., Pass, H., Gazdar, A F., and Minna, J D. p53: a frequent target for genetic abnormalities in lung cancer. Science (Washington DC), 246: 491-494, 1989.
20. Kishimoto, Y., Murakami, Y , Shiraishi, M., Hayashi, K., and Sekiya, T. Aberrations of p53 tumor suppressor gene in human non-small cell carcinomas of the lung. Cancer Res., 52: 4799-4804, 1992
21. Chiba, I , Takahashi, T., Nau, M N , D'Amico, D., Curiel, D. T., Mitsudomi, T., Buchhagen, D. L., Carbone, D., Piantadosi, S., Koga, H., Reissman, P. T., Slamon, D J , Holmes, E. C , and Minna, J. D Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene, 5: 1603-1610, 1990.
22. Suzuki, H , Takahashi, T., Kuroishi, T., Suyama, M., Ariyoshi, Y., Takahashi, T , and Ueda, R. p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking. Cancer Res., 52: 734-736, 1992
23. Prives, C., and Manfredi, J. The p53 tumor suppressor protein; meeting review. Genes & Dev., 7: 529-534, 1993
24. Takahashi, T., Carbone, D , Takahashi, T , Nau, M. M., Hida, T., Linoila, I., Ueda, R , and Minna, J. D. Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions Cancer Res., 52: 2340-2343, 1992
25. Sozzi, G., Miozzo, M., Donghi, R., Pilotti, S., Cariani, C. T., Pastorino, U., Porta, G. P., and Pierotti, M. A. Deletion of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res., 52: 6079-6082, 1992.
26. Klein, N., Vignaud, J M., Sadmi, M., Plenat, F., Borelly, J., Duprez, A , Martinet, Y , and Martinet, N. Squamous metaplasia expression of proto-oncogenes and p53 in lung cancer patients. Lab. Invest , 68: 26-32, 1993.
27. Ryberg, D , Kure, E., Lystad, S., Skaug, V., Stangealand, L., Mercy, I., Børresen, A-L., and Haugen. A. p53 mutations in lung tumors: relationship to putative susceptibility markers for cancer. Cancer Res., 54: 1551-1555, 1994.
28. Puisieux, A., Lim, S., Groopman, J., and Ozturk, M Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens. Cancer Res., 51: 6185-6189, 1991.
29. Ruggeri, B., DiRado, M., Zhang, S. Y., Bauer, B., Goodrow, T., and Klein-Szanto, A. J P Benzo(a)pyrene-induced murine skin tumors exhibit frequent and characteristic G to T mutations in the p53 gene. Proc. Natl. Acad. Sci. USA, 90: 1013-1017, 1993.
30. Strauss, B. S. The origin of point mutations to human tumor cells. Cancer Res., 52 249-253, 1992.
31. The World Health Organization. Histological typing of lung tumors. Am. J. Clin. Pathol , 77: 123-136, 1981.
32. Murakami, Y., Hayashi, K., and Sekiya, T. Detection of aberrations of the p53 alleles and the gene transcript in human tumor cell lines by single-strand conformation polymorphism analysis Cancer Res., 51: 3356-3361, 1991
33. Suzuki, Y., Orita, M., Shiraishi, M., Hayshi, K., and Sekiya, T. Detection of ras gene mutations in human lung cancers by single-stranded conformation polymorphism analysis of polymerase chain reaction products. Oncogene, 5: 1037-1043, 1990
34. Sanger, F , Nicklen, S., and Coulson, A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA, 74: 5463-5467, 1977.
35. Comstock, K. E., Sanderson, J. S., Clafin, G., and Henner, W. D. GST1 gene deletion determined by polymerase chain reaction. Nucleic Acids Res., 18: 3670, 1990.
36. Groppi, A , Coutelle, C , Fleury, B , Iron, A , Begueret, J., and Couzigous, P. Glutathione S-transferase class in French alcoholic cirrhotic patients. Hum. Genet , 87: 628-630, 1991
37. Okada, T., Kawashima, K., Fukushi, S., Minakuchi, T., and Nishimura, S. Association between a cytochrome CYP1A1 genotype and incidence of lung cancer. Pharmacogenetics, 4: 333-340, 1994.
38. Drakoulis, N., Cascorbi, I., Brockmoller, J., Gross, C. R , and Roots, I Polymorphisms in the human CYP1A1 gene as susceptibility factors for lung cancer: exon-7 mutation (4889 A to G) and a T to C mutation in the 3′-flanking region. Clin. Invest., 72: 240-248, 1994.
39. Hamada, G. S., Sugimura, H., Suzuki, I., Nagura, K., Iwase, T , Tanaka, M , Takahashi, T., Watanabae, S., Kino, L. and Tugane, S. The heme-binding region polymorphism of cytochrome P450IA1 (CYP1A1), rather than the Rsa 1 polymorphism of IIE1 (CYPIIE1), is associated with lung cancer in Rio de Janeiro. Cancer Epidemiol., Biomarkers & Prev., 4: 63-67, 1995.
40. 1450) gene: lack of association between the Msp 1 restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population. Pharmacogenetics, 1: 20-25, 1991.
41. Hirvonen, A., Husgafvel-Pursiainen, K , Karjalainen, A., Anttila, S., and Vainio, H Point-mutational Msp 1 and Ile-Val polymorphisms closely linked in the CYP1A1 gene. Lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiol., Biomarkers & Prev , 1: 485-489, 1992
42. Shield, P G , Caporaso, N. E., Falk, R T., Sugimura, H., Trivers, G E., Trump, B F., Hoover, R N., Weston, A., and Harris, C C. Lung cancer, race, and a CYP1A1 genetic polymorphism. Cancer Epidemiol., Biomarkers & Prev., 2: 481-485, 1993
43. Dickey, C. P., Bell, D. A., Santella, R., Ottman, R., Hemminki, K., Savela, K., Lucier, G., and Perera, F P. GSTM1, CYP1A1, Msp 1, and DNA adducts in workers exposed to PAH Proc. Am. Assoc. Cancer Res., 36: 120, 1995.
44. Aaltonen, L. A , Peltomäki, P , Leach, F. S., Sistonen, P., Pylkkänen, L., Mecklin, J-P., Järvinen, H., Powell, S M., Jen, J , Hamilton, S. R , Petersen, G. M., Kinzler, K. W., Vogelstein, B., and de la Chapelle, A. Clues to pathogenesis of familial colorectal cancer. Science (Washington DC), 260: 812-816, 1993.
45. Ionov, Y., Peinado, M. A., Malkhosyan, S., Shibata, D , and Perucho, M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature (Lond.), 363: 558-561, 1993.
46. Rabbitts, P. H., Sundaresan, V., Ganly, P. S., Hasleton, P., Rudd, R. M., and Sinha, G Application of PCR-RFLP analysis to allele loss studies in small biopsies of lung tumors and preinvasive lesions of the lung. Presented at the Third European Workshop on Cytogenetics and Molecular Genetics of Human Solid Tumors, Porto, April 26-29, 1992
47. Knudson, A. G. Antioncogenes and human cancer. Proc. Natl. Acad. Sci. USA, 90: 10914-10921, 1993
48. 1. Proc Natl. Acad. Sci. USA, 92: 2384-2387, 1995.